Company intelligence / Profile preview

EGZOTech

Ownership: Private
Employees: ~77
Development stage: Commercial

Overview

EGZOTech’s Luna EMG robot has CE approval and has been commercially available since mid–2015. The company conducts clinical research to confirm the effectiveness of its devices in improving outcomes for neurological and orthopedic patients. Hundreds of positive testimonials from clinicians support its efficacy.

Therapeutic areas: OtherNeurology
Modalities: DeviceElectromyography-based therapy (EMG)Electrical stimulation therapyRobotic rehabilitation device
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with Silesian University of Technologypartnerships with clinicians, physiotherapists, occupational therapists worldwide

Beyond the preview

Go deeper on EGZOTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EGZOTech.

Explore the full profile